Haermonics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 11

Haermonics General Information

Description

Developer of a medical device designed to prevent blood-related complications after open-heart surgery. The company offers an innovative flushing therapy that reduces blood loss and the need for re-operations, enabling healthcare providers to improve patient recovery and reduce hospital costs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Microlab
  • Kastanjelaan 400
  • 5616 LZ Eindhoven
  • Netherlands
Primary Industry
Surgical Devices
Other Industries
Other Healthcare Technology Systems
Monitoring Equipment
Corporate Office
  • Microlab
  • Kastanjelaan 400
  • 5616 LZ Eindhoven
  • Netherlands

Haermonics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Haermonics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Accelerator/Incubator Completed Clinical Trials - General
7. Later Stage VC 09-Jul-2025 Completed Clinical Trials - General
6. Accelerator/Incubator 30-Sep-2024 Completed Clinical Trials - General
5. Later Stage VC 01-Jun-2024 Completed Clinical Trials - General
4. Later Stage VC (Series A) 08-Aug-2022 Completed Clinical Trials - General
3. Seed Round 25-May-2020 Completed Clinical Trials - General
2. Grant 26-Sep-2016 $829K Completed Startup
1. Seed Round 07-Sep-2015 Completed Startup
To view Haermonics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Haermonics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a medical device designed to prevent blood-related complications after open-heart surgery. The company offe
Surgical Devices
Eindhoven, Netherlands
12 As of 2025

Irvine, CA
 

Omaha, NE
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Haermonics Competitors (3)

One of Haermonics’s 3 competitors is ClearFlow, a Venture Capital-Backed company based in Irvine, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ClearFlow Venture Capital-Backed Irvine, CA
Centese Venture Capital-Backed Omaha, NE
Medela Private Equity-Backed Baar, Switzerland
You’re viewing 3 of 3 competitors. Get the full list »

Haermonics Patents

Haermonics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4694946-A1 System for flushing a body cavity, a measurement unit and a smart tubing assembly for the system Pending 13-Apr-2023
US-20260295140-A1 System for flushing a body cavity, a measurement unit and a smart tubing assembly for the system Pending 13-Apr-2023
WO-2024213694-A1 System for flushing a body cavity, a measurement unit and a smart tubing assembly for the system Inactive 13-Apr-2023
EP-4368218-A1 System for flushing a wound and/or a body cavity, in particular the pericardial cavity Pending 08-Nov-2022
EP-4368219-A1 System for flushing a wound and/or a body cavity, in particular the pericardial cavity Pending 08-Nov-2022 A61M1/734
To view Haermonics’s complete patent history, request access »

Haermonics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Haermonics Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
HTA (Little Rock) Accelerator/Incubator
MedAxiom Corporation
HeartX Accelerator Accelerator/Incubator
Demcon Corporation Minority
Invest-NL (Investment Company) Impact Investing Minority
You’re viewing 5 of 11 investors. Get the full list »

Haermonics FAQs

  • When was Haermonics founded?

    Haermonics was founded in 2015.

  • Where is Haermonics headquartered?

    Haermonics is headquartered in Eindhoven, Netherlands.

  • What is the size of Haermonics?

    Haermonics has 12 total employees.

  • What industry is Haermonics in?

    Haermonics’s primary industry is Surgical Devices.

  • Is Haermonics a private or public company?

    Haermonics is a Private company.

  • What is Haermonics’s current revenue?

    The current revenue for Haermonics is .

  • How much funding has Haermonics raised over time?

    Haermonics has raised $12.1M.

  • Who are Haermonics’s investors?

    HTA (Little Rock), MedAxiom, HeartX Accelerator, Demcon, and Invest-NL (Investment Company) are 5 of 11 investors who have invested in Haermonics.

  • Who are Haermonics’s competitors?

    ClearFlow, Centese, and Medela are competitors of Haermonics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process